Ethics Statement & Publication Malpractice Statement

Adi Husada Nursing Journal publishes peer-reviewed articles and is committed to ensuring ethics in publication and the quality of articles. Integrity in research publication has become a major issue of debate over the past years. To assure the highest standards for published articles, all parties involved in the publishing process (the author, the journal editor(s), the peer reviewer, and the publisher) agree to meet the responsibility of standard publication ethics. The ethics statements for our journal are based on the Committee on Publication Ethics (COPE) Best Practice Guidelines for Journal Editors.

Allegation of Research Misconduct

Research misconduct means fabrication, falsification, citation manipulation, or plagiarism in producing, performing, or reviewing research, writing an article by authors, or reporting research results. When authors are found to have been involved with research misconduct or other serious irregularities involving articles published in scientific journals, Editors have a responsibility to ensure the accuracy and integrity of the scientific record.

In cases of suspected misconduct, the Editors and Editorial Board will use the best practices of COPE to assist them in resolving the complaint and addressing the misconduct fairly. This will include an investigation of the allegation by the Editors. A submitted manuscript that is found to contain such misconduct will be rejected. In cases where a published paper is found to contain such misconduct, a retraction can be published and will be linked to the original article.

The first step involves determining the validity of the allegation and an assessment of whether the allegation is consistent with the definition of research misconduct. This initial step also involves determining whether the individuals alleging misconduct have relevant conflicts of interest.

If scientific misconduct or the presence of other substantial research irregularities is a possibility, the allegations are shared with the corresponding author, who, on behalf of all of the coauthors, is requested to provide a detailed response. After the response is received and evaluated, additional review and involvement of experts (such as statistical reviewers) may be obtained. For cases in which it is unlikely that misconduct has occurred, clarifications, additional analyses, or both, published as letters to the editor, and often including a correction notice and correction to the published article, are sufficient.

Institutions are expected to conduct an appropriate and thorough investigation of allegations of scientific misconduct. Ultimately, authors, journals, and institutions have an important obligation to ensure the accuracy of the scientific record. By responding appropriately to concerns about scientific misconduct and taking necessary actions based on evaluation of these concerns, such as corrections, retractions with replacement, and retractions, Adi Husada Nursing Journal will continue to fulfil the responsibilities of ensuring the validity and integrity of the scientific record.

Complaints and Appeals

Adi Husada Nursing Journal will have a clear procedure for handling complaints against the journal, Editorial Staff, Editorial Board or Publisher. The complaints will be clarified to the respected person with respect to the case of complaint. The scope of complaints includes anything related to the journal business process, i.e. editorial process, found citation manipulation, unfair editor/reviewer, peer-review manipulation, etc. The complaint cases will be processed according to COPE guidelines.

Ethical Oversight

Suppose the research work involves chemicals, humans, animals, procedures, or equipment that have any unusual hazards inherent in their use. In that case, the author must identify these in the manuscript in order to obey the ethical conduct of research using animals and human subjects. The authors must provide legal and ethical clearance from the association or legal organization if required.

If the research involves confidential data and business/marketing practices, the authors should justify this matter, whether the data or information will be hidden securely or not.

Publisher’s confirmation

In cases of alleged or proven scientific misconduct, fraudulent publication, or plagiarism, the publisher, in close collaboration with the Editors-in-Chief, will take all appropriate measures to clarify the situation and amend the article in question. This includes the prompt publication of an erratum or, in the most severe cases, the complete retraction of the affected work.

The Publisher and the Journal do not discriminate based on age, color, religion, creed, disability, marital status, veteran status, national origin, race, gender, genetic predisposition or carrier status, or sexual orientation in its publishing programs, services, and activities.

Data sharing policy (data availability statement) and reproducibility

Adi Husada Nursing Journal accepts the ICMJE recommendations for data sharing policy (http://icmje.org/icmje-recommendations.pdf). All manuscripts reporting clinical trial results should submit a data sharing statement following the ICMJE guidelines. This statement should describe how readers can access the data supporting the conclusions of the study and clearly outline the reasons why unavailable data cannot be released. After acceptance, the corresponding author of the accepted research article should submit the datasets underlying the results of this paper to the editorial office. If the data is already public, its URL site or sources should be disclosed. If the data cannot be publicized, the authors should describe the reason by choosing one of the following examples:
• The datasets generated during and/or analyzed during the current study are available in the [NAME] repository [PERSISTENT WEB LINK TO DATASETS].
• The datasets generated during and/or analyzed during the current study are not publicly available due [REASON WHY DATA ARE NOT PUBLIC] but are available from the corresponding author on reasonable request.
• Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.
• All data generated or analyzed during this study are included in this published article [and its supplementary information files].
• The data that support the findings of this study are available from [third party name] but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. Data are however available from the authors upon reasonable request and with permission of [third party name].

This statement will be required for published articles starting from Vol 11 No 1 (June) 2025.

Disclosure of Artificial Intelligence (AI) Programs

Requirements for reporting use of artificial intelligence–assisted technologies for manuscripts submitted to Adi Husada Nursing Journal (based on recommendations of the International Committee of Medical Journal Editors)
At submission, the Adi Husada Nursing Journal should require authors to disclose whether they used artificial intelligence (AI)-assisted technologies (such as Large Language Models [LLMs], chatbots, or image creators) in the production of submitted work. Authors who use such technology should describe, in both the cover letter and the submitted work, how they used it. Chatbots (such as ChatGPT) should not be listed as authors because they cannot be responsible for the accuracy, integrity, and originality of the work, and these responsibilities are required for authorship. Therefore, humans are responsible for any submitted material that includes the use of AI-assisted technologies. Authors should carefully review and edit the result because AI can generate authoritative-sounding output that can be incorrect, incomplete, or biased. Authors should not list AI and AI assisted technologies as an author or co-author, nor cite AI as an author. Authors should be able to assert that there is no plagiarism in their paper, including in text and images produced by the AI. Humans must ensure there is appropriate attribution of all quoted material, including full citations.
To disclose the use of generative AI and AI-assisted technologies in the writing process, authors must add a statement to the end of their manuscript under a new section called "Declaration of use of AI in the writing process," before the References list.

Statement: The author(s) used [NAME TOOL/SERVICE] during the preparation of this work to [REASON]. After utilizing the tool/service, the author(s) thoroughly reviewed and edited the content as necessary and assumed full responsibility for the publication's content.

This declaration will be required for published articles starting from Vol 3 No 1 (May) 2025.

Post-publication discussions and corrections

The correspondence provides access to the post-publication conversation. If readers have concerns about any of the stories published, they can write a letter to the editor. Errata, corrigenda, and retraction can be used to remedy any errors or faults detected in the article. Each author is responsible for providing early retractions or corrections of inaccuracies in published works. Editors are in charge of any author-requested revisions. After the update request has been accepted, the document will be amended and re-published on our website, along with the posting of a Correction.

Intellectual property

To satisfy the conditions of open access publishing and promote the greatest possible distribution, Adi Husada Nursing Journal requires authors to declare their paper open access under one of the Creative Commons Licenses. The website of Creative Commons describes how these licenses function.

Policies on Conflict of Interest, Human and Animal rights, and Informed Consent

Conflict of Interest Statement
The author is responsible for disclosing any financial support or benefit that might affect the content of the manuscript or might cause a conflict of interest. When submitting the manuscript, the author must attach the letter of conflict of  interest  statement (download coi-statement.docx). Examples of potential conflicts of interest are financial support from or connections to companies, political pressure from interest groups, and academically related issues. In particular, all sources of funding applicable to the study should be explicitly stated.

Statement of Human and Animal Rights
Clinical research should be conducted in accordance with the World Medical Association’s Declaration of Helsinki (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki). Clinical studies that do not meet the Helsinki Declaration will not be considered for publication. For human subjects, identifiable information, such as patients’ names, initials, hospital numbers, dates of birth, and other protected health care information, should not be disclosed. For animal subjects, research should be performed based on the National or Institutional Guide for the Care and Use of Laboratory Animals. The ethical treatment of all experimental animals should be maintained.

Statement of Informed Consent
Subjects must have been properly instructed and have indicated that they consent to participate by signing the appropriate informed consent paperwork. Authors may be asked to submit a blank, sample copy of a subject consent form. If consent was verbal instead of written, or if consent could not be obtained, the authors must explain the reason in the manuscript, and the use of verbal consent or the lack of consent must have been approved by the ethics committee. More information about patient privacy, anonymity, and informed consent can be found in the International Committee of Medical Journal Editors (ICMJE) Privacy and Confidentiality guidelines.